Your browser doesn't support javascript.
loading
Tumor T1 Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model.
Ravoori, Murali K; Nishimura, Masato; Singh, Sheela P; Lu, Chunhua; Han, Lin; Hobbs, Brian P; Pradeep, Sunila; Choi, Hyun J; Bankson, James A; Sood, Anil K; Kundra, Vikas.
Afiliación
  • Ravoori MK; Department of Cancer Systems Imaging, U.T.- M.D. Anderson Cancer Center, Houston, Texas, United States of America.
  • Nishimura M; Department of Obstetrics and Gynecology, The University of Tokushima Graduate School, Tokushima, Japan.
  • Singh SP; Department of Cancer Systems Imaging, U.T.- M.D. Anderson Cancer Center, Houston, Texas, United States of America.
  • Lu C; Department of Gynecologic Oncology, U.T.- M.D. Anderson Cancer Center, Houston, Texas, United States of America.
  • Han L; Department of Cancer Systems Imaging, U.T.- M.D. Anderson Cancer Center, Houston, Texas, United States of America.
  • Hobbs BP; Department of Biostatistics, U.T.- M.D. Anderson Cancer Center, Houston, Texas, United States of America.
  • Pradeep S; Department of Gynecologic Oncology, U.T.- M.D. Anderson Cancer Center, Houston, Texas, United States of America.
  • Choi HJ; Department of Gynecologic Oncology, U.T.- M.D. Anderson Cancer Center, Houston, Texas, United States of America.
  • Bankson JA; Department of Imaging Physics, U.T.- M.D. Anderson Cancer Center, Houston, Texas, United States of America.
  • Sood AK; Department of Gynecologic Oncology, U.T.- M.D. Anderson Cancer Center, Houston, Texas, United States of America; Department of Cancer Biology, U.T.- M.D. Anderson Cancer Center, Houston, Texas, United States of America; Center for RNA Interference and Non-Coding RNA, U.T.- M.D. Anderson Cancer Cente
  • Kundra V; Department of Cancer Systems Imaging, U.T.- M.D. Anderson Cancer Center, Houston, Texas, United States of America; Department of Radiology, U.T.- M.D. Anderson Cancer Center, Houston, Texas, United States of America.
PLoS One ; 10(6): e0131095, 2015.
Article en En | MEDLINE | ID: mdl-26098849
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_mente_y_cuerpo / Relajacion Asunto principal: Neoplasias Ováricas / Inhibidores de la Angiogénesis / Bevacizumab Tipo de estudio: Prognostic_studies Idioma: En Revista: PLoS One Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_mente_y_cuerpo / Relajacion Asunto principal: Neoplasias Ováricas / Inhibidores de la Angiogénesis / Bevacizumab Tipo de estudio: Prognostic_studies Idioma: En Revista: PLoS One Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos